| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 83,671 | 97,084 | 74,977 | | Cost of Revenue | 73,744 | 82,996 | 67,871 | | | Gross Profit | 9,927 | 14,088 | 7,106 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 13,598 | 13,230 | 12,750 | | Non Recurring | 4 | 43 | 17 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (3,675) | 815 | (5,661) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (690) | 330 | (1,118) | | Earnings Before Interest And Taxes | (4,365) | 1,145 | (6,779) | | Interest Expense | 1,150 | 2,048 | 3,074 | | Income Before Tax | (5,515) | (903) | (9,853) | | Income Tax Expense | (354) | 6 | (2,676) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,161) | (909) | (7,177) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (5,161) | (909) | (7,177) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,161) | ($909) | ($7,177) |
|
0.83% Nasdaq 
Income Statement
